Product Code: ETC6186034 | Publication Date: Sep 2024 | Updated Date: Apr 2025 | Product Type: Market Research Report | |
Publisher: 6Wresearch | Author: Vasudha | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
Phototherapy is a standard treatment modality for neonatal jaundice in Australia, and the market continues to expand with the introduction of portable, energy-efficient LED phototherapy units. Both hospitals and home-care providers are adopting advanced phototherapy systems that allow precise wavelength control and reduced treatment times. Market growth is also influenced by public-private partnerships in neonatal healthcare delivery.
The neonatal phototherapy market in Australia is growing due to increasing demand for safer, more effective light therapy solutions for managing jaundice. The market is seeing a shift from conventional halogen and fluorescent lamps to energy-efficient, high-intensity LED phototherapy systems. Portable and home-use phototherapy units are gaining popularity, especially for outpatient treatment models.
The neonatal phototherapy market in Australia is facing challenges related to the proper usage and monitoring of phototherapy devices. Although phototherapy is a widely accepted treatment for jaundice, concerns around its overuse or misuse can lead to complications like skin damage or retinal injury in newborns. Moreover, ensuring that the phototherapy equipment is well-maintained and calibrated to the right intensity is an ongoing challenge. There are also challenges related to providing sufficient access to these devices in remote or under-resourced areas, impacting the efficacy of jaundice treatment across the country.
This market is gaining traction owing to the increasing prevalence of neonatal hyperbilirubinemia and a preference for safer treatment options. Investment in LED-based phototherapy units, which are energy-efficient and provide superior therapeutic results, is a strong prospect. Moreover, expanding collaborations with hospitals and maternity centers can boost access and adoption rates, providing lucrative returns.
Government policies surrounding neonatal phototherapy equipment are driven by the TGA and the National Health and Medical Research Council (NHMRC). The governments regulations ensure that phototherapy devices are safe, effective, and clinically validated. Public hospitals in Australia provide phototherapy as part of standard neonatal care, and reimbursement for such treatments is available through the Medicare Benefits Schedule (MBS). The Australian government also funds research into improving the efficacy of phototherapy and enhancing patient safety during treatment.
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Australia Neonatal Phototherapy Market Overview |
3.1 Australia Country Macro Economic Indicators |
3.2 Australia Neonatal Phototherapy Market Revenues & Volume, 2021 & 2031F |
3.3 Australia Neonatal Phototherapy Market - Industry Life Cycle |
3.4 Australia Neonatal Phototherapy Market - Porter's Five Forces |
3.5 Australia Neonatal Phototherapy Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.6 Australia Neonatal Phototherapy Market Revenues & Volume Share, By Product Type, 2021 & 2031F |
3.7 Australia Neonatal Phototherapy Market Revenues & Volume Share, By Application, 2021 & 2031F |
4 Australia Neonatal Phototherapy Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 Australia Neonatal Phototherapy Market Trends |
6 Australia Neonatal Phototherapy Market, By Types |
6.1 Australia Neonatal Phototherapy Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 Australia Neonatal Phototherapy Market Revenues & Volume, By Type, 2021- 2031F |
6.1.3 Australia Neonatal Phototherapy Market Revenues & Volume, By Convectional Phototherapy Equipment, 2021- 2031F |
6.1.4 Australia Neonatal Phototherapy Market Revenues & Volume, By LED Phototherapy Equipment, 2021- 2031F |
6.1.5 Australia Neonatal Phototherapy Market Revenues & Volume, By Fiber Optic Phototherapy Equipment, 2021- 2031F |
6.2 Australia Neonatal Phototherapy Market, By Product Type |
6.2.1 Overview and Analysis |
6.2.2 Australia Neonatal Phototherapy Market Revenues & Volume, By Traditional Phototherapy Lamps, 2021- 2031F |
6.2.3 Australia Neonatal Phototherapy Market Revenues & Volume, By Phototherapy Beds, 2021- 2031F |
6.2.4 Australia Neonatal Phototherapy Market Revenues & Volume, By Flexible Phototherapy Lamps, 2021- 2031F |
6.3 Australia Neonatal Phototherapy Market, By Application |
6.3.1 Overview and Analysis |
6.3.2 Australia Neonatal Phototherapy Market Revenues & Volume, By Skin Diseases Treatment, 2021- 2031F |
6.3.3 Australia Neonatal Phototherapy Market Revenues & Volume, By Neonatal Jaundice Management, 2021- 2031F |
7 Australia Neonatal Phototherapy Market Import-Export Trade Statistics |
7.1 Australia Neonatal Phototherapy Market Export to Major Countries |
7.2 Australia Neonatal Phototherapy Market Imports from Major Countries |
8 Australia Neonatal Phototherapy Market Key Performance Indicators |
9 Australia Neonatal Phototherapy Market - Opportunity Assessment |
9.1 Australia Neonatal Phototherapy Market Opportunity Assessment, By Type, 2021 & 2031F |
9.2 Australia Neonatal Phototherapy Market Opportunity Assessment, By Product Type, 2021 & 2031F |
9.3 Australia Neonatal Phototherapy Market Opportunity Assessment, By Application, 2021 & 2031F |
10 Australia Neonatal Phototherapy Market - Competitive Landscape |
10.1 Australia Neonatal Phototherapy Market Revenue Share, By Companies, 2024 |
10.2 Australia Neonatal Phototherapy Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |